TrialCNS drugs2013

Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.

Tobias Banaschewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.